KR102241938B9 - 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물 - Google Patents

2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물

Info

Publication number
KR102241938B9
KR102241938B9 KR1020200117862A KR20200117862A KR102241938B9 KR 102241938 B9 KR102241938 B9 KR 102241938B9 KR 1020200117862 A KR1020200117862 A KR 1020200117862A KR 20200117862 A KR20200117862 A KR 20200117862A KR 102241938 B9 KR102241938 B9 KR 102241938B9
Authority
KR
South Korea
Prior art keywords
fucosyllactose
improvement
cardiovascular disease
food composition
cerebral cardiovascular
Prior art date
Application number
KR1020200117862A
Other languages
English (en)
Other versions
KR102241938B1 (ko
Inventor
김경호
신철수
윤종원
전선민
송영하
전옥선
Original Assignee
(주)에이피테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)에이피테크놀로지 filed Critical (주)에이피테크놀로지
Priority to KR1020200117862A priority Critical patent/KR102241938B1/ko
Application granted granted Critical
Publication of KR102241938B1 publication Critical patent/KR102241938B1/ko
Priority to EP21866944.8A priority patent/EP4186512A4/en
Priority to CN202180053133.3A priority patent/CN116347999A/zh
Priority to JP2023513554A priority patent/JP2023540046A/ja
Priority to PCT/KR2021/006498 priority patent/WO2022055073A1/ko
Publication of KR102241938B9 publication Critical patent/KR102241938B9/ko
Priority to US17/993,770 priority patent/US11819510B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
    • A23L29/281—Proteins, e.g. gelatin or collagen
    • A23L29/284—Gelatin; Collagen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020200117862A 2020-09-14 2020-09-14 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물 KR102241938B1 (ko)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020200117862A KR102241938B1 (ko) 2020-09-14 2020-09-14 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물
EP21866944.8A EP4186512A4 (en) 2020-09-14 2021-05-25 FOOD COMPOSITION FOR THE ALLEVIATION OR TREATMENT OF CARDIOCEREBROVASCULAR DISEASE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIOCEREBROVASCULAR DISEASE CONTAINING 2'-FUCOSYLLACTOSE
CN202180053133.3A CN116347999A (zh) 2020-09-14 2021-05-25 包含2′-岩藻糖基乳糖的用于改善心脑血管疾病的食品组合物及用于预防或治疗心脑血管疾病的药物组合物
JP2023513554A JP2023540046A (ja) 2020-09-14 2021-05-25 ２’－フコシルラクトースを含む脳心血管疾患改善用食品組成物及び脳心血管疾患予防又は治療用薬学組成物
PCT/KR2021/006498 WO2022055073A1 (ko) 2020-09-14 2021-05-25 2'-푸코실락토오스를 포함하는 뇌심혈관 질환의 개선용 식품 조성물 및 뇌심혈관 질환의 예방 또는 치료용 약학 조성물
US17/993,770 US11819510B2 (en) 2020-09-14 2022-11-23 Food composition for ameliorating cerebrovascular diseases containing 2′- fucosyllactose and pharmaceutical composition for preventing or treating cerebrovascular diseases containing 2′-fucosyllactose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200117862A KR102241938B1 (ko) 2020-09-14 2020-09-14 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물

Publications (2)

Publication Number Publication Date
KR102241938B1 KR102241938B1 (ko) 2021-04-20
KR102241938B9 true KR102241938B9 (ko) 2022-04-11

Family

ID=75742991

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200117862A KR102241938B1 (ko) 2020-09-14 2020-09-14 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물

Country Status (1)

Country Link
KR (1) KR102241938B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116347999A (zh) 2020-09-14 2023-06-27 高级蛋白质技术公司 包含2′-岩藻糖基乳糖的用于改善心脑血管疾病的食品组合物及用于预防或治疗心脑血管疾病的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224942A1 (en) * 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases
KR20100138438A (ko) * 2009-06-25 2010-12-31 주식회사 한립생명공학 푸코 올리고당을 포함하는 항혈전 조성물
DK2934189T3 (da) * 2012-12-18 2019-11-25 Abbott Lab Humane mælkeoligosaccharider til reduktion af stress-symptomer
BR112017003920A2 (pt) * 2014-09-25 2017-12-12 Nestec Sa sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos)
KR20190130720A (ko) * 2018-05-15 2019-11-25 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 뇌졸중 예방용 조성물

Also Published As

Publication number Publication date
KR102241938B1 (ko) 2021-04-20

Similar Documents

Publication Publication Date Title
ECSP056207A (es) Derivados de 3-alquil y 3-alquenilazetidina sustituidos
FR23C1003I2 (fr) Compositions et leurs utilisations pour le traitement de la Sclérose en plaques
JP2014533699A5 (ko)
ATE501151T1 (de) Substituierte pyrano ä2, 3 - büpyridinderivate als cannabinoid-1 rezeptormodulatoren
WO2014085830A3 (en) Screening assays for therapeutics for parkinson's disease
WO2007136607A3 (en) Substituted esters as cannabinoid-1 receptor modulators
ECSP11011051A (es) Nuevos compuestos 578
WO2008024284A3 (en) Sulfonylated piperazines as cannabinoid-1 receptor modulators
HRP20070505B1 (hr) Spiro-oksindol spojevi i njihove upotrebe kao terapijska sredstva
ECSP045289A (es) Amidas sustituidas
BR112012027640A2 (pt) composto, composição farmacêutica uso de um composto, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 e de tratamento ou prevenção de um distúrbio
WO2012038980A3 (en) Fused tricyclic compounds as adenosine receptor antagonist
KR102241938B9 (ko) 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물
WO2013036912A3 (en) Amido compounds as rorϒtmodulators and uses thereof
EP2344475A4 (en) QUINAZOLINONE, QUINOLONE AND RELATED ANALOGUES AS MODULATORS OF SIRTUINE
DE60316829D1 (de) Substituierte furoä2,3-büpyridin derivate
WO2009155527A3 (en) Phosphatidylinositol 3 kinase inhibitors
EA200900178A1 (ru) Конденсированные гетероциклические производные и их применение
BR112017022568A2 (pt) compostos e seus usos como inibidores de bace1
ECSP088477A (es) Derivados de 3-alquilazetidina sustituidos con heterociclos
BR112012028445A2 (pt) compostos de heteroarila bicíclica como moduladores de gpr119
NZ712479A (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
MA32904B1 (fr) Composes de purine
MA52631A (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
MX2024005493A (es) 2,3,5-trimetil-6-nonilciclohexa-2,5-dien-1,4-diona para suprimir y tratar alfa-sinucleinopatias, tauopatias y otros trastornos.

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]